Fidelity Investments’s Elevation Oncology ELEV Stock Holding History

Fidelity Investments’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-48,868	Closed	-$17.9K	–	5436
2025 Q2	$17.9K	Buy	48,868 +36,885	+308%	+$12.3K	﹤0.01%	4330
2025 Q1	$3.1K	Sell	11,983 -4,458	-27%	-$2.54K	﹤0.01%	4812
2024 Q4	$9.25K	Buy	16,441 +6,724	+69%	+$3.97K	﹤0.01%	4487
2024 Q3	$5.83K	Buy	9,717 +9,712	+194,240%	+$14.4K	﹤0.01%	4588
2024 Q2	$14	Buy	+5	New	+$19	﹤0.01%	5246

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Fidelity Investments's ELEV Position: Q3 2025 in Review

Fidelity Investments sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 48,868 shares — an estimated $17.9K sold.

Fidelity Investments first reported a position in ELEV in Q2 2024 and held it in 5 quarters. The position peaked at $17.9K in Q2 2025. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

Fidelity Investments reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
Fidelity Investments sold 48,868 Elevation Oncology shares in Q3 2025, an estimated $17.9K.
Fidelity Investments first reported a position in Elevation Oncology in Q2 2024 and held it in 5 quarters.
Fidelity Investments's Elevation Oncology position peaked at $17.9K in Q2 2025.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.